Understanding how heavy ion therapy affects pancreatic tumors
Linear energy transfer (LET) dependencies for understanding pancreatic tumor control and relevant molecular endpoints in support of RBE-based heavy-ion radiotherapy
This study is looking at how a special type of radiation therapy, called heavy ion radiotherapy, can help treat pancreatic cancer, and it aims to find better ways to make this treatment work even better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11004604 on NIH RePORTER |
What this research studies
This research investigates the effects of heavy ion radiotherapy on pancreatic ductal adenocarcinoma (PDA) using specialized mouse models and advanced imaging techniques. The team aims to understand how the energy transfer from heavy ions influences tumor control and the molecular responses involved. By combining heavy ion therapy with pharmacological agents that induce cell death, the study seeks to enhance treatment effectiveness against pancreatic cancer. Patients may benefit from insights that could lead to improved therapeutic strategies for advanced pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with advanced pancreatic ductal adenocarcinoma who may be seeking innovative treatment options.
Not a fit: Patients with early-stage pancreatic cancer or those not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with advanced pancreatic cancer, potentially improving survival rates.
How similar studies have performed: Previous research has shown promising results with heavy ion therapy in cancer treatment, indicating potential for success in this novel approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Amundson, Sally a. — Columbia University Health Sciences
- Study coordinator: Amundson, Sally a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.